DOI QR코드

DOI QR Code

Protective Effects on Gastric Lesion of Ursolic acid

Ursolic acid의 위 손상에 대한 방어 효과

  • 김선회 (덕성여자대학교 약학대학) ;
  • 황인영 (덕성여자대학교 약학대학) ;
  • 이선이 (덕성여자대학교 약학대학) ;
  • 정춘식 (덕성여자대학교 약학대학)
  • Received : 2016.05.30
  • Accepted : 2016.07.12
  • Published : 2016.08.30

Abstract

This study is an experiment for gastric protective effects of ursolic acid. In order to identify the effects of ursolic acid on gastrointestinal disorder, acute and chronic gastritis were also observed using HCl ethanol and indomethacin-induced gastric lesion models, respectively. As for gastric acid, it was also identified through proton pump ($H^+/K^+-ATPase$) inhibiting activity. In regards to protective factor for gastric damage, prostaglandin $E_2$ ($PGE_2$) was quantitatively analyzed. Antibacterial activity experiment was done on Helicobacter pylori (H.pylori), which is known to be the causing factor of chronic gastritis, gastric ulcer and gastric cancer. By making use of AGS cell, it was confirmed that ursolic acid was involved in apoptosis of gastric cancer cell through 4',6-diamidino-2-phenylindol (DAPI) staining and flow cytometry analysis. As a result, ursolic acid reduced gastric lesions caused by HCl ethanol and indomethacin. Ursolic acid inhibited acid secretion by inhibiting proton pump ($H^+/K^+-ATPase$), which is the gastric acid secreting enzyme involved at the final phase of gastric acid secretion. And ursolic acid was identified with gastric mucosa protection effects by increasing the concentration of $PGE_2$, a protective factor of gastric mucosa preservation. The antibacterial activity on H. pylori, which is aggressive factor in gastrointestinal disorder, ursolic acid showed inhibitory effects on H. pylori colonization. In the DAPI nuclear staining, unlike the control group, shape of the nucleus has deformed, and has been observed either shrinked cell or chromatin condensation phenomenon. In the Flow cytometry assay, confirmed the growth rate of apoptosis in a concentration-dependent manner.

본 연구에서는 ursolic acid의 위의 보호효과를 위한 실험을 실시하였다. 위장 질병에 대한 ursolic acid의 효과를 확인하기 위해서 급성, 만성위염은 각각의 HCl ethanol과 indomethacin에 의해 유도된 위염 동물 모델을 사용하여 관찰하였다. 대표적인 공격인자인 위산에 관해서는 PPI activity를 통해서 확인하였고, 위의 손상에 대한 보호인자에 관해서는, $PGE_2$를 정량적으로 분석하였다. 항균활성 실험은 만성위염, 위궤양, 위암에 원인인자로 잘 알려진 H. pylori로 실험하였다. AGS cell를 이용하여 DAPI 염색, Flow cytometry assay를 통하여 ursolic acid가 위암세포의 apoptosis에 관여하는지를 확인하였다. 그 결과 ursolic acid는 HCl ethanol과 indomethacin에 의해 유도된 급성, 만성에 대한 위손상을 억제하였다. Ursolic acid는 위산분비의 마지막 단계인 위염분비효소인 proton pump를 억제시킴으로써 산의 분비를 억제하였다. 그리고 ursolic acid는 위 점막의 보호인자인 $PGE_2$의 농도가 증가함으로써 위 점막 보호 효과를 확인하였다. 또한 ursolic acid는 공격인자인 H. pylori colonization을 억제하였다. DAPI를 이용한 핵 염색에서, 대조군과는 달리, 핵 형상의 변형과 함께 수축 된 세포 또는 염색질의 응축현상이 관찰되었다. Flow cytometry assay에서 ursolic acid에 의해 apoptosis가 증가하는 것을 확인 하였다. 이를 통하여 ursolic acid는 위 손상에 대한 방어 효과가 있음을 확인할 수 있었다.

Keywords

References

  1. Yie, Y.Y., Zhao, S.Y., Tang, Q., Zheng, F., Wu, J.J., Yang, L.J., Deng, S.G. and Hann, S.S.: Ursolic acid inhibited growth of hepatocellular carcinoma HepG2 cells through $AMPK{\alpha}$-mediated reduction of DNA methyltransferase., 1. Mol. Cell. Biochem., 402, 63-74 (2014).
  2. Heo, J.K., Hwang, D.S. and Lee, K.S.: Inhibitory Effects of Ursolic Acid from Prunella Vulgaris on Osteoclast Differentiation. J. Korean Obstet. Gynecol., 27, 59-70 (2014). https://doi.org/10.15204/jkobgy.2014.27.2.059
  3. Kim, S.Y., Song, M.J., Roh, B.D., Park, S.H. and Park, J.W.: Inhibition of Streptococcus mutans biofilm formation on composite resins containing ursolic acid. Restorative Dentistry & Endodontics(RDE), 38, 65-72 (2013). https://doi.org/10.5395/rde.2013.38.2.65
  4. Park, S.N. and Kook. J.K.: Antimicrobial Activity of Oleanolic Acid, Ursolic Acid, and Sophoraflavanone G against Periodontopathogens. Intern. J. Oral Biol., 38, 149-154 (2013). https://doi.org/10.11620/IJOB.2013.38.4.149
  5. Jo, E.J., Choi, M.H., Kim, H.S., Park, S.N., Lim, Y.K., Kang, C.K. and Kook, J.K.: Antimicrobial Effects of Oleanolic Acid, Ursolic Acid, and Sophoraflavanone G against Enterococcus faecalis and Propionibacterium acnes. Intern. J. Oral Biol., 39, 75-79 (2014). https://doi.org/10.11620/IJOB.2014.39.2.075
  6. Yu, H.H., Seo, S.J., Hur, J.M., Park, R.K., So, H.S., Jeon, B.H. and You, Y.O.: Protective Effect of Ursolic Acid from Corni fructus on the Hydrogen Peroxide-induced Damage of HEI-OC1 Auditory Cells. Korean J. Orient. Physiol. Pathol., 20, 1524-1529 (2006).
  7. Chu. X., He, X., Shi, Z.P., Li, C.J., Guo, F.C., Li, S.T., Li, Y., Na, L.X. and Sun, C.H.: Ursolic acid increases energy expenditure through enhancing free fatty acid uptake and ${\beta}$-oxidation via an UCP3/AMPK-dependent pathway in skeletal muscle. Molecular Nutrition & Food Research, 59, 1491-1503 (2015). https://doi.org/10.1002/mnfr.201400670
  8. Viver R. Yadav, Sahdeo Prasad, Bokyung sung, Ramaswamy Kannappan, and Bharat B. Aggarwal.: Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer. Toxins, 2, 2428-2466 (2010) https://doi.org/10.3390/toxins2102428
  9. Park, C.E. and Park C.H.: Ursolic Acid Isolated from Mume Fructus Inhibits Urease Activity of Helicobacter pylori. Korean Chem. Eng. Res., 51, 591-596 (2013). https://doi.org/10.9713/kcer.2013.51.5.591
  10. Mizui, T. and Dodeuchi, M.: Effect of polyamines on acidified ethanol induced gastric lesion in rats. Jpn. J. Pharmacol., 33, 939-945 (1983). https://doi.org/10.1254/jjp.33.939
  11. Kasuya, Y., Urushidani, T., and Okabe, S.: Effects of various drugs and vagotomy on indomethacin-induced gastric ulcers in the rat. Jpn. J. Pharmacol., 29, 670-673 (1979). https://doi.org/10.1254/jjp.29.670
  12. Shay, H., Komarov, S.A., Fels, S.S. and Meranze, D.: A simple method for the uniform production of gastric ulceration in the rat. Gastroenterol., 4, 43-61 (1945).
  13. Suetsugu, H., Ishihara, S., Moriyama, N., Kazumori, H., Adachi, K., Fukuda, R., Watanabe, M. and Kinoshita, Y.: Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa, J. Lab. Clin. Med., 136, 50-57 (2000). https://doi.org/10.1067/mlc.2000.107303
  14. Sipponen, P., Kosunen, T.U., Valle, J., Riihela, M. and Seppala, K.: Helicobacter pylori infection and chronic gastritis in gastric cancer, J. Clin. Pathol., 45, 319-323 (1992). https://doi.org/10.1136/jcp.45.4.319
  15. Bae, E.A., Han, M.J., Baek, N.I. and Kim, D.H.: In vitro anti Helicobacter pylori activity of panaxtriol isolated from ginseng. Arch. Pharm. Res., 24, 297-299 (2001). https://doi.org/10.1007/BF02975095
  16. Kim, J.M., Shin, J.E., Han, M.J., Baek, N.I. and Kim, D.H.: Inhibitory Effect of Ginseng Polyacetylenes on Infection and Vacuolation of Helicobacter pylori. Nat. prod. sci., 9, 158-160 (2003).
  17. Aggarwal, B.B., Sung, B., Prasad, S., Yadav, V.R. and Kannappan, R.: Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer, Toxins, 2, 2428-2466 (2010). https://doi.org/10.3390/toxins2102428